Third Wave Technologies launched its Invader hepatitis C virus genotyping reagents. The product enables clinical labs to develop assays that identify all six genotypes of the HCV virus. Physicians prescribe the test to choose a therapy, determine disease progression, and track drug response.
GenVault launched a lab-scale DNA storage system, and said the Intramural Research Program of the National Institute on Aging has ordered two of the platforms.
The NIA uses GenVault’s 384-well microplates, called GenPlates, which hold DNA in a format that can be stored and shipped at room temperature without special biohazard labeling and treatment. (GenVault said data show that DNA is “stably preserved” in this form and that it may be extracted and purified “with a few buffer washes.”